Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep-Oct;28(5):w794-808.
doi: 10.1377/hlthaff.28.5.w794. Epub 2009 Jul 21.

Comparative effectiveness research for antipsychotic medications: how much is enough?

Affiliations

Comparative effectiveness research for antipsychotic medications: how much is enough?

David O Meltzer et al. Health Aff (Millwood). 2009 Sep-Oct.

Abstract

Second-generation antipsychotics have attracted practitioners' and policy-makers' attention, because of concerns over their health effects and costs. Comparative effectiveness data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)-a high-profile National Institutes of Health (NIH)-funded study-have been used to argue for restricting coverage for these costly drugs. But concerns about the design of CATIE and its associated cost-effectiveness analysis and uncertainty about the precision of these findings raise questions about this interpretation. Our work suggests that additional research to increase the precision of comparisons of the effectiveness of antipsychotics would be well worth the cost.

PubMed Disclaimer

Figures

EXHIBIT 3
EXHIBIT 3
Value Of Future Research To Prevalent And Incident Schizophrenia Cohorts At $50,000 Per Quality-Adjusted Life-Year (QALY), 2007–2087 SOURCE: Authors’ calculations. NOTE: CATIE is Clinical Antipsychotic Trials of Intervention Effectiveness.
EXHIBIT 4
EXHIBIT 4
Value Of Research And The Probability That The CATIE Conclusion Is Incorrect (That Perphenazine Is Not Cost-Effective) SOURCE: Authors’ calculations. NOTES: CATIE is Clinical Antipsychotic Trials of Intervention Effectiveness. Maximum value of research (gray line and points) relates to the left-hand y axis. Probability that CATIE conclusion is incorrect (black line and points) relates to the right-hand y axis. QALY is quality-adjusted life-year.
EXHIBIT 5
EXHIBIT 5
Net Expected Value Of Sample Information (At $50,000, $100,000, And $150,000 Per Quality-Adjusted Life-Year, Or QALY) SOURCE: Authors’ calculations.

Similar articles

Cited by

References

    1. Tandon R, Fleischhacker WW. Comparative Efficacy of Antipsychotics in the Treatment of Schizophrenia: A Critical Assessment. Schizophrenia Research. 2005;79(2–3):145–155. - PubMed
    1. This paper uses the commonly used terms “first-generation antipsychotics” and “second-generation anti-psychotics,” which are sometimes called “typical” and “atypical” antipsychotic drugs H.Y Meltzer, “Atypical Antipsychotic Drugs Have Their Merits. Lancet. 2009;373(9668):1007. - PubMed
    1. Kane JM. Tardive Dyskinesia Rates with Atypical Antipsychotics in Adults: Prevalence and Incidence. Journal of Clinical Psychiatry. 2004;65(9 Supp):16–20. - PubMed
    1. We excluded clozapine because of its risk of causing dangerously low white blood cell counts (agranulocytosis), which has limited its approved use for patients who do not respond sufficiently to treatment with other antipsychotic drugs or who cannot tolerate the drug’s greater potential to cause movement disorders.

    1. Kahn RS, et al. Effectiveness of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreni-form Disorder: An Open Randomised Clinical Trial. Lancet. 2008;371(9618):1085–1097. - PubMed
    2. Meltzer HY. Focus on the Metabolic Consequences of Long-Term Treatment with Olanzapine, Quetiapine and Risperidone: Are There Differences? International Journal of Neuropsychopharmacology. 2005;8(2):153–156. - PubMed
    3. Woodward ND, et al. A Meta-Analysis of Neuropsychological Change to Clozapine, Olanzapine, Quetiapine, and Risperidone in Schizophrenia. International Journal of Neuropsychopharmacology. 2005;8(3):457–472. - PubMed
    4. Lagnado L. Prescription Abuse Seen in U.S. Nursing Homes. Wall Street Journal. 2007 December;4

Publication types

Substances

LinkOut - more resources